Skip to main content

Table 3 Summary of data for medication reviews

From: Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial

Category

Variable

Medication dataa Long-term medication (antipsychotic drugs)

• Registered trade name or agent

 

• Dosage form and regimen

 

• Daily dose

 

• Prescription period

 

• Prescribing physician

 

• Indication

PRN medication (antipsychotic drugs)

• Registered trade name or agent

 

• Dosage form

 

• Number of received partial dose

 

• Suggested maximum dose

 

• Prescription period

 

• Prescribing physician

 

• Case of need

Further current long-term and PRN medication

• Registered trade name or agent

• Dose

• Regimen

Medical carea

• Psychopathological reports

• Number of physician contacts (GP, neurologist, psychiatrist, and geriatrician) over the last three months and date of the last visit

• Body weight: current and three months before

 

• Intolerance of drugs

Neuropsychiatric symptomsa (over the last 2 weeks)

• Delusion

• Hallucination

• Aggression

• Verbal abnormality

• Agitation

• Depression

• Anxiety

• Apathy

• Disinhibition

• Irritability

• Sleep disturbances

Potential adverse effects of antipsychotic drugsa (over the last 2 weeks)

• Pain

• Aberrant motor behaviour

• Malposition

• Repetitive behaviour

• Tremor

• Somnolence

• Delirium

Socio-demographic and clinical datab

• Age

• Gender

• Body height

• Relevant clinical diagnoses

• Falls

  1. aSource: routine documentation of residents
  2. bSource: case report form